ARAY » Topics » Item 8.01. Other Events.

This excerpt taken from the ARAY 8-K filed Dec 9, 2008.

Item 8.01.  Other Events.

 

On December 8, 2008, Accuray Incorporated (the “Company”) announced that 150 CyberKnife® Robotic Radiosurgery Systems now have been installed worldwide.

 

The Company issued a press release on December 8, 2008, titled “Accuray Achieves Milestone of 150th CyberKnife System Installed Worldwide” a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Exhibit 99.1 contains forward-looking statements within the meaning of the federal securities laws. These statements are present expectations, and are subject to the limitations listed therein and in the Company’s other SEC reports, including that actual events or results may differ materially from those in the forward-looking statements.

 

This excerpt taken from the ARAY 8-K filed May 8, 2007.

Item 8.01. Other Events.

In connection with the announcement of the results of operations of Accuray Incorporated (the “Company”) for the third quarter of fiscal 2007 and preparation for the announcement of the Company’s installed base of CyberKnife Systems reaching 100 systems, the Company reviewed its installed base data as well as prior disclosures regarding installed CyberKnife Systems.  As a result of this review, the Company is clarifying certain previous disclosures and presenting information regarding the actual number of CyberKnife Systems that are installed in medical facilities and are capable of being used to treat patients.

The Company previously disclosed that as of the end of the first fiscal quarter of 2007, the Company had 83 installed CyberKnife Systems.  This total of 83 systems included a system in Japan that was previously decommissioned and not returned to service.  Accordingly, as of the end of the first quarter of fiscal 2007, the Company had 82 systems that were installed and capable of treating patients.

The Company previously disclosed that as of the end of the second fiscal quarter of 2007, the Company had 91 installed CyberKnife Systems.  This total of 91 systems included the system in Japan referred to above and a system that was sold to a distributor in Italy for installation in a specified hospital but was not installed at the hospital as of the quarter end.  Accordingly, as of the end of the second fiscal quarter of fiscal 2007, the Company had 89 systems that were installed and capable of treating patients.

During the third fiscal quarter of 2007, eight CyberKnife Systems were installed.  Accordingly, as reported in the Company’s announcement of its results of operations for the third quarter of fiscal 2007, as of March 31, 2007 there were 97 CyberKnife Systems installed in medical facilities and capable of treating patients.

The foregoing identification of certain CyberKnife Systems previously included within installed base as systems that are not installed at medical facilities and capable of treating patients will not result in any change in the Company’s revenues for the third quarter of fiscal 2007 or any prior fiscal period.




 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ACCURAY INCORPORATED

 

 

 

 

 

Dated: May 7, 2007

 

By:

 

/s/ Robert E. McNamara

 

 

 

 

Robert E. McNamara
Senior Vice President and Chief Financial Officer

 



This excerpt taken from the ARAY 8-K filed Mar 15, 2007.

Item 8.01.   Other Events.

 

On March 15, 2007, the Company issued a press release announcing its financial results for the quarter ended December 30, 2006. The foregoing description is qualified in its entirety by reference to the Company’s press release dated March 15, 2007, titled “Accuray Incorporated Reports Second Quarter Fiscal 2007 Financial Results”, a copy of which is attached hereto as Exhibit 99.1. The information furnished herein and in the accompanying exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 nor shall it be deemed incorporated by reference in any other filing with the Securities and Exchange Commission except as is expressly set forth by specific reference in such a filing.

 

Forward-Looking Statements.  This report includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  These statements relate to future events or our future financial performance.  In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of those terms and other comparable terminology. These statements reflect only management’s current expectations.  Important factors that could cause actual results to differ materially from the forward-looking statements we make or incorporate by reference in this report are set forth under the heading “Risk Factors” in the Company’s Registration Statement on Form S-1 (Reg. No. 333-138622), as may be updated from time to time by our filings other filings with the Securities and Exchange Commission. If one or more of these risks or uncertainties materialize, or if any underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from any future results, performance or achievements expressed or implied by these forward-looking statements.

 

This excerpt taken from the ARAY 8-K filed Feb 16, 2007.

Item 8.01. Other Events.

On February 13, 2007, Accuray Incorporated (the “Company”) announced the closing of its initial public offering of common stock and the exercise by the underwriters of their over-allotment option to purchase an additional 2,399,998 shares of the Company’s common stock.

A copy of the Company’s press release dated February 13, 2007, titled “Accuray Incorporated Announces Underwriters’ Exercise of Over-Allotment Option and Completion of Initial Public Offering,” is attached hereto as Exhibit 99.1 and is herein incorporated by reference.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki